Innovation Policy Solutions Strengthen Healthcare Legislative and Patient Advocacy Practices


WASHINGTON–(BUSINESS WIRE)–Innovation Policy Solutions LLC (iPolicy), a leading government relations firm that promotes biomedical innovation through policy change, today announced the promotion of Megan Anderson Brooks, PhD, to position of President and the arrival of Lindsey Trischler as Director. In these new roles, Dr. Anderson Brooks and Ms. Trischler will seek to build on the company’s recent success, expand its customer base and enable broader patient access to innovative technologies.

“This is a pivotal time for the company as we seek to strengthen our team, improve our core capabilities and grow our business,” said Jennifer Leib, Founder of Innovation Policy Solutions. “Over the years, Megan has been instrumental in our success through her ability to develop and drive impactful legislative strategies. Lindsey brings a unique ability to build and manage coalitions that have increased patient access to affordable care. I look forward to working with them in these new roles as we seek to help our clients fundamentally change the way research is done, the way medicine is practiced and the way health care is delivered.

Dr. Anderson Brooks will lead the firm’s legislative and appropriations practices. With fifteen years of combined professional experience in scientific research and policy advice, she specializes in implementing federal policy solutions that encourage the use and adoption of innovations in health care and technology. This includes science and regulatory policy related to basic and clinical science research, personalized medicine, federal oversight of diagnostics and biotechnology devices, and patient-specific issues related to access and development of patient-centered treatments. . Earlier in his career, Dr. Anderson Brooks served as a Fellow of the Society for Neuroscience and the New Jersey Department of Health. She received a doctorate in neuroscience from Rutgers University and received a fellowship from the Eagleton Institute of Politics.

Ms. Trischler will be responsible for supporting the firm’s work focused on patient access and coalition building. During her career, she has focused on state and federal policy issues, including patient access to affordable care while working at the International Myeloma Foundation. Ms. Trischler has also been integral in leading a coalition of more than 80 members advocating for federal funding for medical research, prevention and public health. She holds a master’s degree in public administration and policy from American University and a bachelor of arts in communications and public relations from the University of Cincinnati.

About Innovation Policy Solutions

Innovation Policy Solutions (iPolicy) is a leading government affairs consulting firm that promotes innovation through policy change. The firm actively advises and advocates for patients, providers, and innovators in the fields of laboratory medicine, precision medicine, public health, synthetic biology, gene therapy, neuroscience, rare diseases, etc. Drawing on a foundation of scientific expertise, iPolicy identifies data-driven solutions to health and science-policy issues and builds coalitions of support to drive adoption of clinical advances and improve patient access to state-of-the-art diagnostics and treatments. iPolicy is headquartered in Washington and supports clients across the country. For more information, visit


Comments are closed.